CCM
FLGT icon

Cadence Capital Management’s Fulgent Genetics FLGT Stock Holding History

Cadence Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$296K Sell
7,397
-68,788
-90% -$2.15M 0.07% 235
2020
Q2 		$1.22M Sell
76,185
-79,226
-51% -$1.21M 0.18% 184
2020
Q1 		$1.67M Sell
155,411
-8,033
-5% -$112K 0.28% 94
2019
Q4 		$2.11M Buy
+163,444
New +$1.94M 0.23% 118

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJT
Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cadence Capital Management's FLGT Position: Q3 2020 in Review

Cadence Capital Management reduced its Fulgent Genetics (FLGT) stake by 90% in Q3 2020, selling an estimated $2.15M and leaving 7,397 shares worth $296K. The position accounts for 0.07% of the portfolio, ranked #235.

Cadence Capital Management first reported a position in FLGT in Q4 2019 and has held it in 4 quarters since. The position peaked at $2.11M in Q4 2019. 126 funds tracked by Wall St. Rank hold FLGT as of Q3 2020.

  • Cadence Capital Management held 7,397 shares of Fulgent Genetics worth $296K as of Q3 2020.
  • Cadence Capital Management sold 68,788 Fulgent Genetics shares in Q3 2020, an estimated $2.15M.
  • Fulgent Genetics made up 0.07% of Cadence Capital Management's portfolio in Q3 2020, its #235 holding.
  • Cadence Capital Management first reported a position in Fulgent Genetics in Q4 2019 and has held it in 4 quarters since.
  • Cadence Capital Management's Fulgent Genetics position peaked at $2.11M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.